BrightRock Gold Corp (BRGC)

[j$tops]

$NFRM
Products

Our first product is a cytokine inhibitor known as GLB333. This product once used can prevent the action of those molecules and mediators that are involved in the worsening of tissue injury and causing pain. GLB333 is a biopharmaceutical drug in the mid stage of development. The product is believed to have powerful effect on preventing the action of those cytokines that are release around the damaged tissue and lead to sever inflammation and pain. It is our belief this is only breakthrough in the management of systemic tissue injury and treatment of pain.